Market Tracker

09/28 5:27pm ET

Endo International PLC (NASDAQ:ENDP)

22.36
Delayed Data
As of Sep 28
 -0.17 / -0.75%
Today’s Change
12.56
Today|||52-Week Range
72.85
-63.48%
Year-to-Date
Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change
Sep 26 / TheStreet.com - Paid Partner Content
Why Endo International plc Jumped Higher Today
Sep 23 / MotleyFool.com - Paid Partner Content
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
Sep 26 / Zacks.com - Paid Partner Content
Drugmaker Endo rises on leadership change
Sep 23 / FT.com - Paid Partner Content
Company News for September 26, 2016
Sep 26 / Zacks.com - Paid Partner Content
Endo (ENDP) Stock Soars After Campanelli Named CEO
Sep 23 / TheStreet.com - Paid Partner Content
Changes at the Top for Endo Could Benefit Its Smaller Partners
Sep 26 / TheStreet.com - Paid Partner Content
Wallace Weitz's Largest 2nd-Quarter Trades
Sep 22 / GuruFocus News - Paid Partner Content
Why Twitter, Endo International, and Hyster-Yale Materials Handling Jumped Today
Sep 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close22.53
Today’s open22.30
Day’s range21.81 - 22.70
Volume4,538,272
Average volume (3 months)7,574,463
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.12%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.11-0.09%
UTHRUnited Therapeutics ...-3.34-2.74%
TSROTESARO Inc-3.62-3.35%
IONSIonis Pharmaceutical...-0.52-1.42%
Data as of 4:14pm ET, 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.83
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts